James Wallace to Humans
This is a "connection" page, showing publications James Wallace has written about Humans.
Connection Strength
0.022
-
Shared Goal Setting in Team-Based Geriatric Oncology. J Oncol Pract. 2016 11; 12(11):1115-1122.
Score: 0.005
-
Randomized Phase Ib/II Study of Gemcitabine Plus Placebo or Vismodegib, a Hedgehog Pathway Inhibitor, in Patients With Metastatic Pancreatic Cancer. J Clin Oncol. 2015 Dec 20; 33(36):4284-92.
Score: 0.004
-
Treatment rationale and study design for a randomized, double-blind, placebo-controlled phase II study evaluating onartuzumab (MetMAb) in combination with bevacizumab plus mFOLFOX-6 in patients with previously untreated metastatic colorectal cancer. Clin Colorectal Cancer. 2013 Sep; 12(3):218-22.
Score: 0.004
-
Dasatinib in previously treated metastatic colorectal cancer: a phase II trial of the University of Chicago Phase II Consortium. Invest New Drugs. 2012 Jun; 30(3):1211-5.
Score: 0.003
-
Cancer in long-term care. Clin Geriatr Med. 2011 May; 27(2):301-27.
Score: 0.003
-
Gemcitabine plus sorafenib in patients with advanced pancreatic cancer: a phase II trial of the University of Chicago Phase II Consortium. Invest New Drugs. 2012 Feb; 30(1):382-6.
Score: 0.003